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Acinetobacter baumannii is a species of nonfermentative gram-negative bacteria commonly found in water and soil.
This organism was susceptible to most antibiotics in the 1970s. It has now become a major cause of hospital-acquired
infections worldwide due to its remarkable propensity to rapidly acquire resistance determinants to a wide range of
antibacterial agents. Here we use a comparative genomic approach to identify the complete repertoire of resistance
genes exhibited by the multidrug-resistant A. baumannii strain AYE, which is epidemic in France, as well as to
investigate the mechanisms of their acquisition by comparison with the fully susceptible A. baumannii strain SDF,
which is associated with human body lice. The assembly of the whole shotgun genome sequences of the strains AYE
and SDF gave an estimated size of 3.9 and 3.2 Mb, respectively. A. baumannii strain AYE exhibits an 86-kb genomic
region termed a resistance island—the largest identified to date—in which 45 resistance genes are clustered. At the
homologous location, the SDF strain exhibits a 20 kb-genomic island flanked by transposases but devoid of resistance
markers. Such a switching genomic structure might be a hotspot that could explain the rapid acquisition of resistance
markers under antimicrobial pressure. Sequence similarity and phylogenetic analyses confirm that most of the
resistance genes found in the A. baumannii strain AYE have been recently acquired from bacteria of the genera
Pseudomonas, Salmonella, or Escherichia. This study also resulted in the discovery of 19 new putative resistance genes.
Whole-genome sequencing appears to be a fast and efficient approach to the exhaustive identification of resistance
genes in epidemic infectious agents of clinical significance.
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Introduction
The prevalence of nosocomial infections in hospital
intensive care units due to Acinetobacter baumannii currently
ranges from 2% to 10% of all gram-negative bacterial
infections in Europe [1] and account for about 2.5% of them
in the United States [2]. A. baumannii exhibits a remarkable
ability to rapidly develop antibiotic resistance that led to
multidrug resistance (MDR) within a few decades [3]. To date,
some strains of A. baumannii have become resistant to almost
all currently available antibacterial agents [4], mostly through
the acquisition of plasmids [5], transposons [6], or integrons
[7,8] carrying clusters of genes encoding resistance to several
antibiotic families [6–8] at once. With the emergence of
increasingly resistant strains, the management of A. baumannii
infections has become a public health problem in many
countries. Recently, a high incidence of MDR A. baumannii
bloodstream infections in US Army service members injured
during Afghanistan and Iraq/Kuwait military operations was
reported [9]. To date, no study has been designed to
investigate at once the various resistance mechanisms
involved in the acquisition of an MDR phenotype by a given
A. baumannii strain. We had the opportunity to cultivate the
MDR A. baumannii strain AYE, which is resistant to b-lactams
(except imipenem, piperacillin-tazobactam, and ticarcillin-
clavulanate), aminoglycosides, ﬂuoroquinolones, chloram-
phenicol, tetracycline, and rifampin; is epidemic in 54
healthcare facilities in eight French administrative regions;
and is associated with a mortality of 26% of infected patients
[8]. Simultaneously, we also cultured the remarkably suscep-
tible strain SDF, which is associated with human body lice
[10]. We used a whole-genome sequencing approach to
compare the gene content of A. baumannii AYE and SDF
strains, with a special emphasis on gene categories related to
antibacterial resistance. The parallel genome sequence
annotation of both strains allowed us to identify all genes
associated with previously known antibiotic resistance, and,
unexpectedly, to discover that most of these genes were
clustered in an 86-kb region, or ‘‘island,’’ of the A. baumannii
strain AYE genome. To our knowledge, this is the largest
resistance island described to date. In addition, we discovered
19 putative resistance genes not previously described in A.
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antibacterial resistance genes indicates that frequent genetic
exchanges take place with Pseudomonas spp., Salmonella spp., or
Escherichia spp.
Results
Shotgun Genome Sequences of A. baumannii Strains AYE
and SDF
A preliminary assembly of the whole shotgun genome
sequences of the strains AYE and SDF, as described below in
Materials and Methods, led to a size estimate of 3.9 Mb and
3.2 Mb, respectively, with GþC contents of 38.8% and 38.2%.
In addition to their main chromosomes, the AYE and SDF
strains harbor three plasmids (5, 9, and 94 kb) and two
plasmids (6 and 25 kb), respectively. Surprisingly, none of the
plasmids carry any known resistance marker. A detailed
analysis of these two genome sequences will be published
elsewhere; the present report focuses on the genes predicted
to be involved in antibacterial resistance that, as expected,
were found to account for the main difference in gene
complement between A. baumannii strains AYE and SDF.
These genes, together with the type of antibacterial resistance
they display, are listed in Tables 1–3.
An 86-kb Resistance Island in A. baumannii Strain AYE
The AYE strain genome encoded 52 genes predicted to be
associated with resistance to antimicrobial drugs, while only
seven were identiﬁed in the SDF strain genome. Interestingly,
45 (86.5%) of the 52 AYE resistance genes are tightly
clustered in an 86,190-bp genomic region disrupting a
putative ATPase open reading frame (ORF) (Figures 1 and
2). The insertion site was identical in the two strains (Figure 1)
and the insert was ﬂanked at both extremities by a ﬁve-
nucleotide direct repeat (ACCGC). This repetition is likely
due to a duplication, which suggests a transposition mecha-
nism for the insertion. However, no inverted repeats
characteristic of transposons were found at the extremities
of the island. The 86-kb region was classiﬁed as a genomic
island (and designated AbaR1) on the basis of its size (.10
kb), marked G þ C content difference from the rest of the
chromosomes (52.8% versus 38.8%), the presence of genes
associated with genome instability such as integrases, trans-
posases, and insertion sequences, and the diverse phyloge-
netic origin of the associated ORFs [11]. At the same position,
ﬂanked by identical nucleotide sequences and within the
homologous ATPase ORF, the A. baumannii strain SDF
genome sequence exhibits a genomic island (designated
AbaG1), albeit only 19,632 bp in length, with a GþC content
of 31.3% (Figure 1). This shorter genomic island encodes 25
putative ORFs, 12 of which had a match in databases, but only
ten of which were assigned a function: four transposases, a
transposition helper, a thymidylate synthase, anthranilate
synthase components 1 and 2, a putative D-aminolevulinic
acid dehydratase, and a mutT/NUDIX hydrolase (Figure 3).
Detailed sequence comparison of the two islands failed to
reveal any signiﬁcant similarity, including among the trans-
posases found at their extremities.
Genomic islands containing resistance markers are referred
to as resistance islands [12]. Resistance islands have been
described mainly in c-proteobacteria, including Shigella
ﬂexneri, Salmonella enterica, and Vibrio cholerae, but also in
Staphylococcus aureus [11]. Their sizes range from 20 to 60 kb
[11]. The AbaR1 resistance island speciﬁc to the A. baumannii
AYE strain is thus, at 86 kb, to our knowledge the largest
described to date, encoding 88 predicted ORFs, 82 of which
could be assigned a predicted function (Figure 2, Tables 1–3).
According to amino acid sequence similarities greater than
90% in most cases, 39 genes (44%) are likely to have
originated from Pseudomonas spp., 30 (34%) from Salmonella
spp., 15 (17%) from Escherichia spp., and four (4%) from other
microorganisms. Of the 45 resistance genes, 25 are associated
with various classes of antibiotics. These include genes that
had not been previously described in Acinetobacter species: strA,
strB, aphA1, and aac69 (resistance to aminoglycosides); putative
tetracycline-resistance genes tetA (tetracycline efﬂux pump)
and tetR (repressor); dfrX (resistance to cotrimoxazole); and
the chloramphenicol-resistance gene cmlA (chloramphenicol
efﬂux pump). In addition, genes previously found in Acineto-
bacter species were identiﬁed, including those that encode the
b-lactamases VEB-1 and OXA-10; the aminoglycoside acetyl
transferase gene aac3 and the aminoglycoside adenylyltrans-
ferases aadA1/DA1/B; the cotrimoxazole resistance-associated
dfrI; tetA and tetR; cmlA5 and one copy of the chloramphenicol
acetyl-transferase cat; the rifampin ADP-ribosyltransferase
gene arr-2; and ﬁve copies of the sulfonamide-resistance gene
sulI encoding dihydropteroate synthetase, a component of
class 1 integrons. The annotated sequences of the AbaR1 and
AbaG1 islands, which include the genes discussed above, have
been deposited in the EMBL database.
Antiseptic Resistance-Associated Genes in A. baumannii
Strain AYE
The AbaR1 also encodes two complete operons, one
associated with arsenic resistance [13] and the second with
mercury resistance (Figure 2) [14]. The latter is widely
distributed both in clinical strains of gram-negative bacteria
and in environmental bacterial strains [15]. The arsenic-
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A. baumannii Multidrug Resistance Genes
Synopsis
The bacterial species Acinetobacter baumannii is a major cause of
hospital-acquired infection throughout the world, and it is an
increasing public health concern due to its increasing resistance to
antibiotic treatment. Coincidently, a high incidence of multidrug-
resistant A. baumannii bloodstream infections was recently reported
in US Army service members injured during Afghanistan and Iraq/
Kuwait military operations. A. baumannii exhibits a remarkable
ability to rapidly develop antibiotic resistance, which led from fully
susceptible to multidrug-resistant strains within three decades. The
authors used whole-genome sequencing and bioinformatic analyses
to identify the complete repertoire of resistance genes exhibited by
the multidrug-resistant A. baumannii strain AYE, which is epidemic
in France, and to investigate the mechanisms of their acquisition by
comparison with the fully susceptible A. baumannii strain SDF, which
is associated with human body lice. This study led to the discovery
in the AYE genome of an 86-kb region called a resistance ‘‘island’’—
the largest identified to date—that contains a cluster of 45
resistance genes. The homologous location in the susceptible strain,
curiously, exhibited a 20-kb genomic island that is devoid of
resistance markers. This ability to ‘‘switch’’ its genomic structure
probably explains the unmatched speed at which A. baumannii
captures resistance markers when under antibacterial pressure, such
as is found in hospital intensive care units.T
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A. baumannii Multidrug Resistance Genesresistance operon lacks the arsAa n darsDg e n e s[ 1 6 ]
associated with high levels of resistance to both arsenic and
antimony, but it includes arsH and arsR, which have not been
found previously in Acinetobacter species. In addition, two
genes encoding heavy metal efﬂux pumps, and four qacED1
genes encoding small multidrug resistance (SMR)-family
efﬂux pumps, known to confer a low level of resistance to
ammonium antiseptics, are scattered throughout the AbaR1
resistance island. The qacED1 genes were probably not
acquired independently, as they are parts of the structure
of class 1 integrons.
Fine Structure of the AbaR1 Resistance Island
Fourteen of the antibiotic resistance genes could be
mapped to three class 1 integrons (Figure 2). One integron
carries dfrI [17]. A second integron is a composite made of a
complete class 1 integron identiﬁed in P. aeruginosa [8], which
carries
blaVEB-1,
blaOXA-10, arr-2, cmlA, aadA1 [18], and a
duplication of the 39-conserved segment region that includes
orf513 and dfrX cassettes. Such additional genes have been
observed in In6-like class 1 integrons [19]. The third integron
encodes aac3a n daadDA1 [20]. No other integron was
detected outside of AbaR1 in the AYE strain genome, nor
in the SDF strain genome.
In addition to integrons, a record 22 ORFs encoding
transposases or other mobility-associated proteins were
identiﬁed in the AbaR1 resistance island, suggesting that
transposons are central to the island dynamic and the rapid
acquisition of foreign resistance genes by the A. baumannii
AYE strain. For instance, the island exhibits a near perfect
duplication of a cluster of four genes including pbrR (a heavy
metal-associated cation efﬂux transporter-encoding gene),
lspA (lipoprotein signal peptidase gene), and a gene encoding
a tnpA-like transposase (Figure 2). Such a gene cluster was
previously encountered in a Pseudomonas putida transposable
element (ISPpu12) [21]. Another four transposons, previously
described in Acinetobacter spp. or other bacteria, were found
within AbR1. These included a truncated Tn5393 transposon
made of strA, strB, and tnpM [22]; a truncated Tn1721
transposon comprising tetR, tetA, pecM, and tnpA [22]; an IS1-
like transposable element including ybjA, cat, insA, and insB
[23]; and a Tn21-like transposon made of tnpA, urf2y, and the
mercury-resistance operon [24]. Another ﬁve insertion
sequences from the IS15 and IS26 classes were found in
AbR1, including two IS26 that ﬂanked the aphA1 gene. In
addition, the remaining ﬁve genes involved in antibiotic
resistance were located near a transposase gene, thus
suggesting a possible role of transposition in their acquis-
ition.
Genomic islands are unstable regions and hotspots for the
successive integration of resistance determinants in Salmonella
spp., Escherichia coli, or Streptococcus thermophilus [12]. We can
safely assume that the mosaic-like structure of the AbaR1
island is the result of successive acquisitions of DNA
fragments from different hosts [12], mainly Pseudomonas
spp., Salmonella spp., and E. coli (Figure 2). We also identiﬁed
a cluster of genes similar to a fragment of the Salmonella
genomic island 1 that comprises cmlA, tetR, tetA, lysR, a
transposase-like gene, and a GroEL-integrase fusion protein-
encoding gene [25]. However, no obvious mechanism for
these integrations is suggested by the structure of the A.
baumannii genome. Although AbaR1 contains many genes
T
a
b
l
e
3
.
C
o
n
t
i
n
u
e
d
.
T
r
a
n
s
p
o
r
t
e
r
G
e
n
e
F
a
m
i
l
y
G
e
n
e
N
a
m
e
P
r
e
d
i
c
t
e
d
S
p
e
c
i
f
i
c
i
t
y
A
b
a
R
1
L
o
c
a
t
i
o
n
A
l
s
o
P
r
e
s
e
n
t
i
n
A
.
b
a
u
m
a
n
n
i
i
S
D
F
(
%
A
m
i
n
o
A
c
i
d
I
d
e
n
t
i
t
y
)
G
e
n
B
a
n
k
M
a
t
c
h
w
i
t
h
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
p
.
(
%
A
m
i
n
o
A
c
i
d
I
d
e
n
t
i
t
y
)
B
e
s
t
M
a
t
c
h
I
f
N
o
t
i
n
A
c
i
n
e
t
o
b
a
c
t
e
r
(
%
A
m
i
n
o
A
c
i
d
I
d
e
n
t
i
t
y
)
1
7
_
3
8
U
n
k
n
o
w
n
N
o
(
C
T
0
2
5
9
4
5
)
Y
e
s
(
9
9
%
)
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
.
A
D
P
1
(
8
0
%
)
[
3
2
]
C
a
t
i
o
n
/
m
u
l
t
i
d
r
u
g
e
f
f
l
u
x
p
u
m
p
(
3
6
_
4
4
0
)
N
o
(
C
T
0
2
5
8
2
0
)
Y
e
s
(
9
9
%
)
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
.
A
D
P
1
(
8
3
%
)
[
3
2
]
M
A
T
E
f
a
m
i
l
y
3
6
_
5
0
3
U
n
k
n
o
w
n
N
o
(
C
T
0
2
5
8
2
1
)
Y
e
s
(
9
4
%
)
N
o
B
.
b
r
o
n
c
h
i
s
e
p
t
i
c
a
(
3
7
%
)
[
6
7
]
3
6
_
1
2
7
U
n
k
n
o
w
n
N
o
(
C
T
0
2
5
8
1
8
)
Y
e
s
(
9
9
%
)
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
.
A
D
P
1
(
8
3
%
)
[
3
2
]
S
M
R
f
a
m
i
l
y
6
_
1
6
5
U
n
k
n
o
w
n
N
o
(
C
T
0
2
5
8
2
9
)
Y
e
s
(
9
9
%
)
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
.
A
D
P
1
(
8
3
%
)
[
3
2
]
A
B
C
s
u
p
e
r
f
a
m
i
l
y
2
_
6
9
4
U
n
k
n
o
w
n
N
o
(
C
T
0
2
5
8
0
4
)
Y
e
s
(
9
8
%
)
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
.
A
D
P
1
(
8
2
%
)
[
3
2
]
D
M
T
f
a
m
i
l
y
P
e
r
m
e
a
s
e
(
3
1
_
3
4
9
)
U
n
k
n
o
w
n
N
o
(
C
T
0
2
5
8
0
6
)
Y
e
s
(
9
9
%
)
N
o
P
.
f
l
u
o
r
e
s
c
e
n
s
(
6
4
%
)
(
Z
P
_
0
0
2
6
7
4
7
2
)
A
P
C
f
a
m
i
l
y
D
-
s
e
r
i
n
e
/
D
-
a
l
a
n
i
n
e
/
g
l
y
c
i
n
e
t
r
a
n
s
p
o
r
t
p
r
o
t
e
i
n
(
4
1
_
1
3
8
)
A
m
i
n
o
a
c
i
d
s
N
o
(
C
T
0
2
5
8
2
2
)
Y
e
s
(
9
4
%
)
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
.
A
D
P
1
(
8
7
%
)
[
3
2
]
D
-
s
e
r
i
n
e
/
D
-
a
l
a
n
i
n
e
/
g
l
y
c
i
n
e
t
r
a
n
s
p
o
r
t
p
r
o
t
e
i
n
(
4
1
_
1
4
1
)
A
m
i
n
o
a
c
i
d
s
N
o
(
C
T
0
2
5
8
2
3
)
Y
e
s
(
9
2
%
)
A
c
i
n
e
t
o
b
a
c
t
e
r
s
p
.
A
D
P
1
(
8
2
%
)
[
3
2
]
A
b
b
r
e
v
i
a
t
i
o
n
s
:
A
m
g
,
a
m
i
n
o
g
l
y
c
o
s
i
d
e
s
;
c
l
o
,
c
h
l
o
r
a
m
p
h
e
n
i
c
o
l
;
e
r
y
,
e
r
y
t
h
r
o
m
y
c
i
n
;
E
t
h
B
r
,
E
t
h
i
d
i
u
m
b
r
o
m
i
d
e
;
f
l
u
,
f
l
u
o
r
o
q
u
i
n
o
l
o
n
e
s
;
t
e
t
,
t
e
t
r
a
c
y
c
l
i
n
e
s
;
t
r
i
,
t
r
i
m
e
t
h
o
p
r
i
m
.
D
O
I
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
g
e
n
.
0
0
2
0
0
0
7
.
t
0
0
3
PLoS Genetics | www.plosgenetics.org January 2006 | Volume 2 | Issue 1 | e7 0067
A. baumannii Multidrug Resistance GenesFigure 1. Comparison of Insertion Sites of the AbaR1 and AbaG1 Islands in an ATPase ORF
Insertion sites of the AbaR1 (A) and AbaG1 (B) islands in an interrupted ATPase-encoding ORF are compared. ORFs 1_837 and 1_434 in strain AYE, and
1_126 and 1_87 in strain SDF, retain a strong similarity to the 39 and 59 fragments, respectively, of the ATPase sequence encoded by Acinetobacter strain
ADP1 [32]. The 5-bp direct repeats flanking the islands are underlined.
DOI: 10.1371/journal.pgen.0020007.g001
Figure 2. Layout of the Complete AbaR1 Inserted into the AYE Strain ATPase-Encoding Gene
The nomenclature of each ORF is indicated. Each ORF is identified according to EMBL entry CT025832. Colors are used to indicate ORF categories:
resistance to antibiotics in red, resistance to heavy metals or antiseptics in blue, transposases in brown, integrases in yellow, and other functionsi n
white. Genes exhibiting a best matching homolog in Pseudomonas are underlined in green, in yellow for Salmonella, in light blue for E. coli, and in
turquoise for other bacteria. Complete integrons are indicated by red dashed lines. Transposons are indicated by blue dashed lines. Black dashed lines
indicate a gene cluster found in Salmonella genomic island 1.
DOI: 10.1371/journal.pgen.0020007.g002
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A. baumannii Multidrug Resistance Genesfound on plasmids in other bacteria, it is devoid of plasmid
markers. It has been proposed that a strain of A. calcoaceticus
could stably integrate antibiotic resistance genes carried by
an R plasmid into its chromosome, and then discard the
plasmid [6]. Such a mechanism could have occurred in the A.
baumannii AYE strain. Another possible acquisition mecha-
nism might involve natural transformation [26]. Transforma-
tion has been demonstrated in Acinetobacter spp. [27–31]. As a
matter of fact, the ﬁrst genome of an Acinetobacter spp. to be
sequenced was that of the highly transformable Acinetobacter
spp. strain ADP1 [32]. The close evolutionary proximity of
Acinetobacter spp. and Pseudomonas spp. may facilitate direct
gene exchanges between them.
Antibacterial Resistance Genes outside of the Genomic
Islands
In addition to the two b-lactamase genes located in AbaR1,
three others were identiﬁed in AYE: the previously described
ampC [33,34], surprisingly absent from the SDF strain, and
two new putative b-lactamases (Table 1), both of which had
orthologs in the SDF strain. One of them, a class D-type
oxacillinase named
blaOXA-69, was demonstrated to have a
narrow-spectrum hydrolysis proﬁle including, at low level,
imipenem and meropenem [35]. We also identiﬁed an ORF
encoding a 43-kDa porin that is homologous to the
Acinetobacter heat-modiﬁable protein A [36]. The reduction
in the expression of this porin, in concordance with the
presence of an OXA-24 oxacillinase, is thought to play a role
in carbapenem resistance in A. baumannii [37]. However, no
ortholog to OXA-24 has been found in the AYE strain, and
the level of expression of the putative porin is unknown.
Additional ORFs encoding a putative aminoglycoside
adenylyltransferase and a tetracycline efﬂux pump tetA were
also found in both A. baumannii strains. As these putative
resistance genes did not confer a resistant phenotype to the
SDF strain, their exact function is not known. In contrast,
only the AYE strain exhibited a Ser ! Leu mutation at
positions 83 and 80 of the gyrA and parC genes, respectively,
that confer resistance to ﬂuoroquinolones [38].
An additional 46 ORFs putatively associated with resistance
to antimicrobials were identiﬁed in the AYE strain. These
ORFs encoded putative efﬂux pumps from the resistance-
nodulation-cell division (RND) family (32 ORFs), major
facilitator superfamily (MFS) family (seven ORFs), multidrug
and toxic efﬂux (MATE) family (two ORFs), SMR family (one
ORF), ATP binding cassette (ABC) superfamily (one gene),
drug/metabolite transporter (DMT) family (one gene), and
amino acids, polyamines, organic cations (APC) transporter
family (two genes) (Table 3). Among the RND gene family, the
AYE strain, but not the SDF strain, exhibited the AdeABC
efﬂux pump-encoding genes (adeA, adeB, and adeC) and their
regulating genes adeR and adeS. However, the latter two genes
did not exhibit the Thr153 ! Met or Pro116 ! Leu
mutations previously associated with an MDR phenotype
[39]. Finally, both strains AYE and SDF possess the adeIJK
efﬂux pump (encoded by adeI, adeJ, and adeK).
Most of the genes associated with competence in Acineto-
bacter strain ADP1 [31,32,40] were identiﬁed in the sequences
of the AYE and SDF strains (to be described elsewhere).
However, as we have no direct evidence of natural trans-
formation in these isolates, and as a single missing gene may
kill the function, it is not yet certain that these genes play a
signiﬁcant role in the acquisition of new resistance genes.
Discussion
This study demonstrates the usefulness of comparative
genome sequencing for a rapid survey of all putative
resistance mechanisms in A. baumannii. The determination
and detailed comparison of the genome sequences of the
MDR strain AYE, and the strain SDF, which is free from most
resistance acquired by A. baumannii over recent decades,
allowed the identiﬁcation of many genes associated with
antibacterial resistance at once. We identiﬁed 52 genes
associated with resistance in the AYE strain, including 17
genes not, to our knowledge, previously described in A.
baumannii. The clustering of 45 (86.5%) of them within an 86-
kb AbaR1 resistance island was unexpected.
Figure 3. Layout of the Complete AbaG1 Inserted into the SDF Strain ATPase-Encoding Gene
The nomenclature of each ORF is indicated. Each ORF is identified according to EMBL entry CT025833. ORF categories are indicated by colors:
transpositions in brown and other functions in white. The phylogenetic origin of genes is highlighted by color markers. Dashed lines indicate genes
found in the same order in other bacteria.
DOI: 10.1371/journal.pgen.0020007.g003
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A. baumannii Multidrug Resistance GenesThe detailed sequence analysis of the AbaR1 island, the
largest genomic island identiﬁed to date, showed that it was
built through the recursive insertion of broad host-range
mobile genetic elements (transposons, gene cassettes from
class 1 integrons), with gene cassettes (sometimes chimeric)
mostly originating from the genera Pseudomonas, Salmonella,
and Escherichia. Together with A. baumannii, many members of
these genera are commonly found in aqueous environments
of healthcare facilities, where, under antimicrobial pressure
in these settings, genetic exchange among them may be
promoted.
Another unexpected ﬁnding was the presence of a similar
structure in the genome of susceptible strain SDF, identi-
cally inserted in the homologous ATPase-like ORF. This
genomic island was found in an ‘‘empty’’ state, exhibiting
mobility-associated genes but no resistance markers. This
coincidental genetic insertion in the two strains strongly
suggests that this ATPase ORF constitutes a speciﬁc hotspot
of genomic instability in the A. baumannii genome. This
prompted us to investigate whether this feature was
common to all A. baumannii strains. Using a polymerase
chain reaction assay based on the conserved ATPase ORF
ﬂanking sequences (Protocol S1), 17 (77%) out of the 22
clinical A. baumannii isolates were found to exhibit an intact
ATPase ORF. These 17 isolates included 11 isolates resistant
to several antibiotic families, including b-lactams, and six
susceptible to b-lactams. Among the ﬁve isolates exhibiting
an interrupted ATPase ORF, four were resistant to most b-
lactams except imipenem, including some that were also
resistant to other antibiotic families, and one was suscep-
tible to b-lactams but resistant to cotrimoxazole and
rifampin (Protocol S1). The presence of a genomic island
within the ATPase ORF is thus not a conserved feature
among isolates, and its absence at this location is not
predictive of the observed pattern of antibiotic suscepti-
bility. This suggests a particular ﬂexibility of the A. baumannii
genome, in line with its exceptional ability in gathering
foreign genetic material. Whole-genome sequencing of
additional A. baumannii strains will be needed to assess the
full range of mechanisms through which clinical isolates can
so efﬁciently acquire new resistance genes.
Finally, our last surprise was the identiﬁcation of several
putative resistance genes in a strain not exhibiting the
associated phenotype. This was the case for two putative b-
lactamases (present in the AYE and SDF), including the class
D b-lactamase
blaOXA-69. The expression of OXA-69 in E. coli
resulted in low levels of carbapenem resistance [35], and its
sequence is 97% identical to the OXA-51 carbapenemase,
found associated with full carbapenem resistance [41].
However, the presence of
blaOXA-69 in the susceptible AYE
strain suggests that it might only be a step away from
acquiring this new resistance through subtle changes in
expression level or a speciﬁc mutation or series of mutations
that alter the substrate proﬁle and enhance catalytic activity.
Besides the direct acquisition of genetic material from
resistant bacterial species, the maintenance of spare copies
of ‘‘ready-to-optimize’’ resistance genes in the genome of A.
baumannii, perhaps selected by exposure to subinhibitory
levels of the drug in the environment, might also play a role
in its rapid adaptation to new derivatives of the major
antibiotic classes.
Materials and Methods
A. baumannii strains. Strains AYE and SDF were identiﬁed as A.
baumannii using both phenotypic (API 20NE system; BioMerieux,
Marcy l’Etoile, France) and genotypic methods [8,10]. Both strains
were grown on trypticase-soy agar (BioMerieux).
Sequencing. Genomic DNA of AYE and SDF strains was mechan-
ically sheared and fragments of 6 kb and 14 kb were cloned into two
plasmid vectors, pNAV (A) and pCNS (B) (pcDNA2.1- and pSU18-
derived, respectively). Plasmid DNAs were puriﬁed and end-
sequenced by dye-terminator chemistry on ABI3730 sequencers
(Applied Biosystems, Foster City, California, United States). The
PHRED/PHRAP/CONSED software package was used for sequence
assemblies. Gap closure and quality assessment were made for AbaR1
and AbaG1 islands.
Annotation. Initially, a preliminary set of putative ORFs of 300
nucleotides or more of both shotgun genome sequences was obtained.
These included a proportion of hypothetical ORFs. The ORF
nomenclature used in this study refers to this initial step. Then, the
coding potential of ORFs was evaluated using the SelfID program, and
systematic sequence similarity search of ORFs was conducted against
the NCBI nonredundant protein database using the gapped BLASTP
program. Gene identities were obtained using a reciprocal best match
strategy. ORFs with neither coding potential nor similarity were no
longer considered. Tentative ORF functions were assigned on the basis
ofsequencesimilarityagainstproteinsequencedatabases(KEGG,COG,
SWISSPROT, and the nonredundant protein database) and domain/
motif databases (Pfam and PROSITE). Orthologous versus paralogous
relationships were identiﬁed with multiple sequence alignments and
neighbor-joining trees constructed by ClustalW. The functional
classiﬁcation was based on the scheme provided by the Acinetobacter
spp. ADP1 genome project [32] as well as that provided by KEGG.
Sources of software and databases. The PHRED/PHRAP/CONSED
software package is available at http://www.phrap.com. The SelfID
program is available at http://igs-server.cnrs-mrs.fr/;audic/selﬁd.tgz.
The gapped BLAST program is available at http://www.ncbi.nlm.nih.
gov/BLAST. KEGG is available at http://www.genome.jp/kegg. COG is
available at http://www.ncbi.nlm.nih.gov/COG. SWISSPROT is avail-
able at http://www.expasy.org/sprot. Pfam is available at http://pfam.
wustl.edu. PROSITE is available at http://www.expasy.org/prosite.
Supporting Information
Protocol S1. Molecular Detection of Genomic Islands in Clinical
Isolates of A. baumannii
Found at DOI: 10.1371/journal.pgen.0020007.sd001 (25 KB DOC).
Accession Numbers
The EMBL (http://www.ebi.ac.uk/embl) accession numbers for the
resistance islands in the two A. baumannii strains are, for AYE, AbaR1
(CT025832); and for SDF, AbaG1 (CT025833). Other genes discussed,
also in the EMBL database, are adeA (CT025811), adeB (CT025812), adeC
(CT025813), adeI (CT025787), adeJ (CT025788), adeK (CT025790), adeR
(CT025814), adeS (CT025815), aminoglycoside adenylyltransferase
(CT025824), ampC (CT025798), a putative b-lactamase (CT025947),gyrA
(CT025946), parC (CT025948), tetA (AM086635). The GenBank (http://
www.ncbi.nlm.nih.gov) accession number of
blaOXA-69 is AY859527.
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